137 related articles for article (PubMed ID: 32793477)
1. Bacterial Cyclodipeptides Target Signal Pathways Involved in Malignant Melanoma.
Durán-Maldonado MX; Hernández-Padilla L; Gallardo-Pérez JC; Díaz-Pérez AL; Martínez-Alcantar L; Reyes De la Cruz H; Rodríguez-Zavala JS; Pacheco-Rodríguez G; Moss J; Campos-García J
Front Oncol; 2020; 10():1111. PubMed ID: 32793477
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect of bacterial cyclodipeptides in the HeLa line of human cervical cancer reveals multiple protein kinase targeting, including mTORC1/C2 complex inhibition in a TSC1/2-dependent manner.
Hernández-Padilla L; Reyes de la Cruz H; Campos-García J
Apoptosis; 2020 Oct; 25(9-10):632-647. PubMed ID: 32617785
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma.
Lázaro-Mixteco PE; González-Coronel JM; Hernández-Padilla L; Martínez-Alcantar L; Martínez-Carranza E; López-Bucio JS; Guevara-García ÁA; Campos-García J
Front Oncol; 2022; 12():790537. PubMed ID: 35359411
[TBL] [Abstract][Full Text] [Related]
4. The Antiproliferative Effect of Cyclodipeptides from Pseudomonas aeruginosa PAO1 on HeLa Cells Involves Inhibition of Phosphorylation of Akt and S6k Kinases.
Hernández-Padilla L; Vázquez-Rivera D; Sánchez-Briones LA; Díaz-Pérez AL; Moreno-Rodríguez J; Moreno-Eutimio MA; Meza-Carmen V; Cruz HR; Campos-García J
Molecules; 2017 Jun; 22(6):. PubMed ID: 28632179
[No Abstract] [Full Text] [Related]
5. The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
Hernández-Padilla L; Durán-Maldonado MX; Martínez-Alcantar L; Rodríguez-Zavala JS; Campos-Garcia J
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38629372
[TBL] [Abstract][Full Text] [Related]
6. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
7. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
8. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma.
Calero R; Morchon E; Martinez-Argudo I; Serrano R
Cancer Lett; 2017 Oct; 406():1-11. PubMed ID: 28774796
[TBL] [Abstract][Full Text] [Related]
10. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract][Full Text] [Related]
11. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
[TBL] [Abstract][Full Text] [Related]
12. Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.
Wei BR; Michael HT; Halsey CH; Peer CJ; Adhikari A; Dwyer JE; Hoover SB; El Meskini R; Kozlov S; Weaver Ohler Z; Figg WD; Merlino G; Simpson RM
Pigment Cell Melanoma Res; 2016 Nov; 29(6):643-655. PubMed ID: 27463366
[TBL] [Abstract][Full Text] [Related]
13. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
[TBL] [Abstract][Full Text] [Related]
14. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.
Kou Y; Li L; Li H; Tan Y; Li B; Wang K; Du B
Biochem Biophys Res Commun; 2016 Oct; 479(2):290-296. PubMed ID: 27639645
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
Li CY; Wang Q; Wang X; Li G; Shen S; Wei X
Eur J Pharmacol; 2019 Sep; 858():172463. PubMed ID: 31211986
[TBL] [Abstract][Full Text] [Related]
16. Resistance to ursolic acid-induced apoptosis through involvement of melanogenesis and COX-2/PGE2 pathways in human M4Beu melanoma cancer cells.
Hassan L; Pinon A; Limami Y; Seeman J; Fidanzi-Dugas C; Martin F; Badran B; Simon A; Liagre B
Exp Cell Res; 2016 Jul; 345(1):60-9. PubMed ID: 27262506
[TBL] [Abstract][Full Text] [Related]
17. [Study of gambogenic acid-induced apoptosis of melanoma B16 cells through PI3K/Akt/mTOR signaling pathways].
Cheng H; Zhang X; Su JJ; Li QL
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1666-9. PubMed ID: 25095381
[TBL] [Abstract][Full Text] [Related]
18. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways.
Liang G; Liu M; Wang Q; Shen Y; Mei H; Li D; Liu W
Oncotarget; 2017 Apr; 8(17):28510-28525. PubMed ID: 28212537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
